Skip to content

DALEMANS: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

DALEMANS

BE 0419.971.002
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€22,317
2024 · €22,738-€45,054
Equity
€500,348
2024 · €522,665-€22,317
Cash
€60,253
2024 · €348,228-€287,975
Balance sheet total
€1.2m
2024 · €980,171+€217,728

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€563,365

    up €563,365 (+197.8%), from €284,868 to €848,233

    of which Land and buildings: +€305,168

  • Cash -€287,975

    down €287,975 (-82.7%), from €348,228 to €60,253

    mainly Investment in fixed assets (net) (-€599,503) and Trade debts (-€31,783)

  • Receivables within one year -€73,787

    down €73,787 (-30.5%), from €241,832 to €168,045

    of which Other amounts receivable: -€86,168

  • Stocks and contracts +€14,193

    up €14,193 (+16.3%), from €87,087 to €101,280

Equity and liabilities
  • Debts after one year +€187,600

    up €187,600 (+83.6%), from €224,308 to €411,908

  • Other debts +€60,961

    up €60,961 (+57.5%), from €105,936 to €166,896

  • Trade debts -€31,783

    down €31,783 (-29.9%), from €106,371 to €74,587

  • Reserves -€22,317

    down €22,317 (-4.4%), from €503,665 to €481,348

    of which Distributable reserves: -€16,317

  • Current portion of long-term debt +€19,005

    up €19,005 (+219.2%), from €8,669 to €27,674

Income statement
  • Depreciation +€22,027

    up €22,027 (+156.1%), from €14,111 to €36,138

  • Staff costs +€15,184

    new in 2025: €15,184

  • Financial charges +€9,194

    up €9,194 (+53.9%), from €17,066 to €26,260

  • Taxes -€7,779

    no longer reported in 2025 (was €7,779)

  • Other operating charges +€6,709

    up €6,709 (+341.0%), from €1,968 to €8,677

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €22,738
Gross operating margin +€318
Staff costs -€15,184
Depreciation -€22,027
Other operating charges -€6,709
Financial income -€37
Financial charges -€9,194
Taxes +€7,779
Result 2025 -€22,317

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€104,923
Investment -€599,503
Financing +€206,605
Cash 2024 €348,228
Net result for the year -€22,317
Depreciation +€36,138
Stocks and contracts -€14,193
Receivables within one year +€73,787
Deferred charges and accrued income -€1,932
Trade debts -€31,783
Tax, wage and social debts +€2,399
Other debts +€60,961
Accrued charges and deferred income +€1,864
Investment in fixed assets (net) -€599,503
Debts after one year +€187,600
Current portion of long-term debt +€19,005
Cash 2025 €60,253
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €980,171 €1,197,899 +€217,728 +22.2%
Fixed assets 21/28 €284,868 €848,233 +€563,365 +197.8%
Tangible fixed assets 22/27 €284,868 €848,233 +€563,365 +197.8%
Land and buildings 22 €278,508 €583,676 +€305,168 +109.6%
Plant, machinery and equipment 23 €2,410 €52,257 +€49,847 +2068.4%
Furniture and vehicles 24 €3,950 €212,300 +€208,350 +5274.6%
Current assets 29/58 €695,303 €349,666 -€345,636 -49.7%
Stocks and contracts in progress 3 €87,087 €101,280 +€14,193 +16.3%
Stocks 30/36 €87,087 €101,280 +€14,193 +16.3%
Amounts receivable within one year 40/41 €241,832 €168,045 -€73,787 -30.5%
Trade receivables 40 €57,043 €69,424 +€12,381 +21.7%
Other amounts receivable 41 €184,788 €98,620 -€86,168 -46.6%
Current investments 50/53 €18,129 €18,129 = 0.0%
Cash at bank and in hand 54/58 €348,228 €60,253 -€287,975 -82.7%
Deferred charges and accrued income 490/1 €28 €1,960 +€1,932 +6953.1%
Total equity and liabilities 10/49 €980,171 €1,197,899 +€217,728 +22.2%
Equity 10/15 €522,665 €500,348 -€22,317 -4.3%
Contributions 10/11 €19,000 €19,000 = 0.0%
Reserves 13 €503,665 €481,348 -€22,317 -4.4%
Tax-exempt reserves 132 €6,063 €63 -€6,000 -99.0%
Distributable reserves 133 €497,602 €481,285 -€16,317 -3.3%
Amounts payable 17/49 €457,506 €697,551 +€240,045 +52.5%
Amounts payable after more than one year 17 €224,308 €411,908 +€187,600 +83.6%
Financial debts 170/4 €224,308 €411,908 +€187,600 +83.6%
Amounts payable within one year 42/48 €228,745 €279,327 +€50,582 +22.1%
Current portion of amounts payable after more than one year 42 €8,669 €27,674 +€19,005 +219.2%
Trade debts 44 €106,371 €74,587 -€31,783 -29.9%
Suppliers 440/4 €106,371 €74,587 -€31,783 -29.9%
Taxes, remuneration and social security 45 €7,770 €10,169 +€2,399 +30.9%
Taxes 450/3 €7,770 €10,169 +€2,399 +30.9%
Other amounts payable 47/48 €105,936 €166,896 +€60,961 +57.5%
Accrued charges and deferred income 492/3 €4,453 €6,316 +€1,864 +41.9%
Remuneration, social security and pensions 62 - €15,184 +€15,184
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €14,111 €36,138 +€22,027 +156.1%
Other operating charges 640/8 €1,968 €8,677 +€6,709 +341.0%
Gross operating margin 9900 €63,329 €63,647 +€318 +0.5%
Operating profit (loss) 9901 €47,251 €3,648 -€43,603 -92.3%
Financial income 75/76B €332 €295 -€37 -11.0%
Recurring financial income 75 €332 €295 -€37 -11.0%
Financial charges 65/66B €17,066 €26,260 +€9,194 +53.9%
Recurring financial charges 65 €17,066 €26,260 +€9,194 +53.9%
Profit (loss) for the period before taxes 9903 €30,517 -€22,317 -€52,833
Income taxes 67/77 €7,779 - -€7,779
Profit (loss) for the period 9904 €22,738 -€22,317 -€45,054
Transfer from tax-exempt reserves 789 - €6,000 +€6,000
Profit (loss) for the period to be appropriated 9905 €22,738 -€16,317 -€39,054

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.